Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)

China · Delayed Price · Currency is CNY

59.24

-0.89 (-1.48%)

Sep 9, 2026, 4:00 PM EDT

Market Cap	4.68B +27.2%
Revenue (ttm)	143.26M -32.3%
Net Income	-48.14M
EPS	-0.60
Shares Out	78.96M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	712,300
Open	60.14
Previous Close	60.13
Day's Range	59.00 - 60.36
52-Week Range	39.10 - 98.29
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHE:301075

Tibet Duo Rui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical formulations, chemical intermediates, and peptide APIs in China. It offers fluid therapy, anesthesiology medication, analgesic medication, and first-aid medication products, as well as multiple electrolytes injection; sodium acetate ringer's injection. Tibet Duo Rui Pharmaceutical Co., Ltd. was founded in 2005 and is headquartered in Tibet, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2005

Employees 461

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301075

Full Company Profile

Financial Performance

In 2025, SHE:301075's revenue was 154.18 million, a decrease of -35.93% compared to the previous year's 240.63 million. Losses were -102.17 million, 63.0% more than in 2024.

Financial Statements